GS-9411

N/A

Report date: 2022/07/19 16:22:54

NME

Base Information

Drug NameGS-9411

Drug Alias NameP-680GS-9411

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionEpithelial sodium channel blockers

TargetsEpithelial sodium channel

Therapy Area/IndicationsCystic Fibrosis

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryAustralia

CombinationsNo

Global Highest StatusDiscontinued (Phase 1 Clinical)

Highest Status in ChinaN/A

Originator CompaniesParion Sciences Inc

China Registration ClassN/A

Active CompaniesN/A

Active IndicationsN/A

Inactive IndicationsCystic Fibrosis

ATC CodeN/A